Diabetes 53:221-227, 2004
© 2004 by the American Diabetes Association, Inc.
Familial Hyperinsulinemic Hypoglycemia Caused by a Defect in the SCHAD Enzyme of Mitochondrial Fatty Acid Oxidation
Anders Molven1,
Guri E. Matre1,
Marinus Duran2,
Ronald J. Wanders2,
Unni Rishaug3,
Pål R. Njølstad1,4,
Egil Jellum5, and
Oddmund Søvik4
1 Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
2 Laboratory for Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, the Netherlands
3 Department of Endocrinology, Aker University Hospital, Oslo, Norway
4 Institute for Clinical Medicine and Molecular Medicine, Department of Pediatrics, University of Bergen, Bergen, Norway
5 Institute of Clinical Biochemistry, National Hospital, Oslo, Norway
Inappropriately elevated insulin secretion is the hallmark of persistent hyperinsulinemic hypoglycemia of infancy (PHHI), also denoted congenital hyperinsulinism. Causal mutations have been uncovered in genes coding for the ß-cells ATP-sensitive potassium channel and the metabolic enzymes glucokinase and glutamate dehydrogenase. In addition, one hyperinsulinemic infant was recently found to have a mutation in the gene encoding short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), an enzyme participating in mitochondrial fatty acid oxidation. We have studied a consanguineous family with severe neonatal hypoglycemia due to increased insulin levels and where well-established genetic causes of hyperinsulinism had been eliminated. A genome-wide, microsatellite-based screen for homozygous chromosomal segments was performed. Those regions that were inherited in accordance with the presupposed model were searched for mutations in genes encoding metabolic enzymes. A novel, homozygous deletion mutation was found in the gene coding for the SCHAD enzyme. The mutation affected RNA splicing and was predicted to lead to a protein lacking 30 amino acids. The observations at the molecular level were confirmed by demonstrating greatly reduced SCHAD activity in the patients fibroblasts and enhanced levels of 3-hydroxybutyryl-carnitine in their blood plasma. Urine metabolite analysis showed that SCHAD deficiency resulted in specific excretion of 3-hydroxyglutaric acid. By the genetic explanation of our familys cases of severe hypoglycemia, it is now clear that recessively inherited SCHAD deficiency can result in PHHI. This finding suggests that mitochondrial fatty acid oxidation influences insulin secretion by a hitherto unknown mechanism.
Address correspondence and reprint requests to Prof. Anders Molven, Department of Pathology, The Gade Institute, Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway. E-mail: anders.molven{at}gades.uib.no

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. A. Martens, A. Vervoort, M. Van de Casteele, G. Stange, K. Hellemans, H. V. Van Thi, F. Schuit, and D. Pipeleers
Specificity in Beta Cell Expression of L-3-Hydroxyacyl-CoA Dehydrogenase, Short Chain, and Potential Role in Down-regulating Insulin Release
J. Biol. Chem.,
July 20, 2007;
282(29):
21134 - 21144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. T. Hardy, H. E. Hohmeier, T. C. Becker, E. Manduchi, N. M. Doliba, R. K. Gupta, P. White, C. J. Stoeckert Jr, F. M. Matschinsky, C. B. Newgard, et al.
Functional Genomics of the {beta}-Cell: Short-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Regulates Insulin Secretion Independent of K+ Currents
Mol. Endocrinol.,
March 1, 2007;
21(3):
765 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Nolan, M. S.R. Madiraju, V. Delghingaro-Augusto, M.-L. Peyot, and M. Prentki
Fatty Acid Signaling in the {beta}-Cell and Insulin Secretion
Diabetes,
December 1, 2006;
55(Supplement_2):
S16 - S23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. van Hove, T. Hansen, J. M. Dekker, E. Reiling, G. Nijpels, T. Jorgensen, K. Borch-Johnsen, Y. H. Hamid, R. J. Heine, O. Pedersen, et al.
The HADHSC Gene Encoding Short-Chain L-3-Hydroxyacyl-CoA Dehydrogenase (SCHAD) and Type 2 Diabetes Susceptibility: The DAMAGE Study
Diabetes,
November 1, 2006;
55(11):
3193 - 3196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Vatamaniuk, R. K. Gupta, K. A. Lantz, N. M. Doliba, F. M. Matschinsky, and K. H. Kaestner
Foxa1-Deficient Mice Exhibit Impaired Insulin Secretion due to Uncoupled Oxidative Phosphorylation.
Diabetes,
October 1, 2006;
55(10):
2730 - 2736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Zinnanti, J. Lazovic, E. B. Wolpert, D. A. Antonetti, M. B. Smith, J. R. Connor, M. Woontner, S. I. Goodman, and K. C. Cheng
New insights for glutaric aciduria type I.
Brain,
August 1, 2006;
129(Pt 8):
e55 - e55.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, A. Matter, A. Kelly, T. J. Petty, H. Najafi, C. MacMullen, Y. Daikhin, I. Nissim, A. Lazarow, J. Kwagh, et al.
Effects of a GTP-insensitive Mutation of Glutamate Dehydrogenase on Insulin Secretion in Transgenic Mice
J. Biol. Chem.,
June 2, 2006;
281(22):
15064 - 15072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gremlich, C. Nolan, R. Roduit, R. Burcelin, M.-L. Peyot, V. Delghingaro-Augusto, B. Desvergne, L. Michalik, M. Prentki, and W. Wahli
Pancreatic Islet Adaptation to Fasting Is Dependent on Peroxisome Proliferator-Activated Receptor {alpha} Transcriptional Up-Regulation of Fatty Acid Oxidation
Endocrinology,
January 1, 2005;
146(1):
375 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tornovsky, A. Crane, K. E. Cosgrove, K. Hussain, J. Lavie, M. Heyman, Y. Nesher, N. Kuchinski, E. Ben-Shushan, O. Shatz, et al.
Hyperinsulinism of Infancy: Novel ABCC8 and KCNJ11 Mutations and Evidence for Additional Locus Heterogeneity
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6224 - 6234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Fourtner and C. A. Stanley
Genetic and Nongenetic Forms of Hyperinsulinism in Neonates
NeoReviews,
September 1, 2004;
5(9):
e370 - e376.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Struys, E. E.W. Jansen, N. M. Verhoeven, and C. Jakobs
Measurement of Urinary D- and L-2-Hydroxyglutarate Enantiomers by Stable-Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry after Derivatization with Diacetyl-L-Tartaric Anhydride
Clin. Chem.,
August 1, 2004;
50(8):
1391 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|